Plenary Session

397 Episodo

1. 5.06 - POLO trial now has OS results - OMG

   Publicado: 21/7/2022
2. 5.05 - Citations, Metrics, Rankings in Oncology & Medicine

   Publicado: 18/7/2022
3. 5.04 - Echelon 1 reports OS benefit - But does it add up?

   Publicado: 14/7/2022
4. 5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?

   Publicado: 13/7/2022
5. 5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers

   Publicado: 11/7/2022
6. 5.01 - How To Read Randomized Trials In Cancer

   Publicado: 7/7/2022
7. Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health

   Publicado: 22/6/2022
8. Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer

   Publicado: 20/6/2022
9. Kids Vaccine For Under 5 years Old

   Publicado: 18/6/2022
10. H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189

    Publicado: 18/6/2022
11. QuANTUM - Quizartinib Front Line - Ethics of Global Trials

    Publicado: 15/6/2022
12. 4.67 Teclistimab for R/R Multiple Myeloma

    Publicado: 9/6/2022
13. 4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

    Publicado: 8/6/2022
14. 4.65 DESTINY BREAST 04 - A complex trial to deconstruct

    Publicado: 7/6/2022
15. 4.64 - DETERMINATION - Should we still use transplant Myeloma?

    Publicado: 6/6/2022
16. 4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

    Publicado: 5/6/2022
17. 4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

    Publicado: 4/6/2022
18. 4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

    Publicado: 27/5/2022
19. 4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

    Publicado: 21/5/2022
20. 4.59 - How to be a better reader of case control studies

    Publicado: 17/5/2022